Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Net Income (2009 - 2026)

Updated

Astrazeneca's Net Income came in at $2.51 billion for Q2 2026, up 2.5% from $2.45 billion a year earlier but down 18.6% from the prior quarter.

Analysis

Astrazeneca (AZN) Net Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Net Income of $10.45 billion, up 25.9% year-over-year; for FY2025, it was $10.23 billion, up 45.3% from FY2024.

  • Net Income has increased in each of the last three years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • Going back by year, Net Income was $7.04 billion in FY2024 (+18.1%), $5.96 billion in FY2023 (+81.0%), $3.29 billion in FY2022 and $115 million in FY2021 (-96.3%).
  • The five-year range for quarterly Net Income is -$1.65 billion (Q3 2021) to $3.08 billion (Q1 2026).
  • Year-over-year, Net Income has increased for 11 consecutive quarters, with growth averaging 32.7% over the last eight quarters.
  • The fastest year-over-year change in Net Income over five years came in Q2 2023 (growth of 405.6%), and the weakest in Q1 2022 (a decline of 75.2%).
  • Business Quant data shows AZN's Net Income at $3.08 billion (Q1 2026), $2.33 billion (Q4 2025) and $2.54 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.51 Bn
Mar 31, 2026 3.08 Bn
Dec 31, 2025 2.33 Bn
Sep 30, 2025 2.54 Bn
Jun 30, 2025 2.45 Bn
Mar 31, 2025 2.92 Bn
Dec 31, 2024 1.50 Bn
Sep 30, 2024 1.43 Bn
Jun 30, 2024 1.93 Bn
Mar 31, 2024 2.18 Bn
Dec 31, 2023 959.00 Mn
Sep 30, 2023 1.38 Bn
Jun 30, 2023 1.82 Bn
Mar 31, 2023 1.80 Bn
Dec 31, 2022 902.00 Mn
Sep 30, 2022 1.64 Bn
Jun 30, 2022 360.00 Mn
Mar 31, 2022 388.00 Mn
Dec 31, 2021 -346.00 Mn
Sep 30, 2021 -1.65 Bn
API Access

Astrazeneca Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=AZN&period=max&api_key=YOUR_API_KEY